Tech Company Financing Transactions
MicroBiome Therapeutics Funding Round
MicroBiome Therapeutics, operating out of New Orleans, secured $1.3 million from BVM Capital and private investors.
Transaction Overview
Company Name
Announced On
12/17/2013
Transaction Type
Venture Equity
Amount
$1,300,000
Round
Undisclosed
Investors
BVM Capital (Lead Investor)
Proceeds Purpose
These additional funds will enable us to complete our ongoing studies and prepare for our next set of clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5500 Prytania St. 530
New Orleans, LA 70115
USA
New Orleans, LA 70115
USA
Phone
Website
Email Address
Not Recorded
Overview
MicroBiome Therapeutics is developing medical food and pharmaceutical products that improve health status by interacting with the human microbiome in specific ways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Elstrott
Chief Executive Officer
Dale Pfost
Chief Scientific Officer
Mark Heiman
Browse more venture capital transactions:
Prev: 12/17/2013: Coskata venture capital transaction
Next: 12/17/2013: Entitle venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs